Neil S Horowitz
Overview
Explore the profile of Neil S Horowitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
151
Citations
1996
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tyan K, Liu K, Smart A, Feltmate C, Horowitz N, Muto M, et al.
Gynecol Oncol
. 2025 Mar;
195:75-81.
PMID: 40058185
Background: There are limited data around adjuvant radiotherapy following surgical management for patients with early-stage uterine carcinosarcoma (UCS). We compared outcomes for patients with early-stage UCS who underwent adjuvant chemotherapy...
2.
Barcellos M, Braga A, Rech M, de Oliveira S, Madi J, Sun S, et al.
Clinics (Sao Paulo)
. 2025 Mar;
80:100583.
PMID: 40031424
Objective: To assess the performance of pembrolizumab for the treatment of Gestational Trophoblastic Neoplasia (GTN). Methods: The Medical Subject Headings related to immunotherapy/pembrolizumab and GTN were used alone or in...
3.
Horowitz N, St Laurent J, Berkowitz R
Gynecol Oncol
. 2025 Feb;
193:A1-A2.
PMID: 40021246
No abstract available.
4.
Rauh-Hain J, Melamed A, Pareja R, May T, Sinno A, McNally L, et al.
JAMA Netw Open
. 2024 Nov;
7(11):e2446325.
PMID: 39570589
Importance: Despite the absence of high-quality evidence of its safety and effectiveness, minimally invasive surgery (MIS) is increasingly used to treat advanced epithelial ovarian cancer (EOC). Objective: To assess the...
5.
Elias K, Berkowitz R, Horowitz N
Hematol Oncol Clin North Am
. 2024 Sep;
38(6):1259-1264.
PMID: 39341707
Ultra high-risk gestational trophoblastic neoplasia (GTN) refers to patients with World Health Organization prognostic risk scores of at least 13. The mortality risk for these patients averages 30%. Ultra high-risk...
6.
Alimena S, Elias K, Horowitz N, Berkowitz R
Hematol Oncol Clin North Am
. 2024 Sep;
38(6):1233-1244.
PMID: 39327132
Gestational trophoblastic neoplasia (GTN) is a rare form of cancer that is treated according to the World Health Organization (WHO) risk score, which predicts responsiveness to single-agent chemotherapy. Patients with...
7.
Wang V, Elias K, Berkowitz R, Horowitz N
Hematol Oncol Clin North Am
. 2024 Sep;
38(6):1277-1286.
PMID: 39322463
Placental site trophoblastic disease (PSTT) and epithelioid trophoblastic tumor (ETT) are the rarest forms of gestational trophoblastic neoplasia (GTN) with unique clinical features and treatment considerations. Unlike other GTN, human...
8.
Braga A, Paiva G, Alevato R, Saldanha P, Elias K, Horowitz N, et al.
Hematol Oncol Clin North Am
. 2024 Sep;
38(6):1245-1258.
PMID: 39322460
High-risk gestational trophoblastic neoplasia encompasses patients with high volumes of disease or diffuse metastatic involvement who are unlikely to achieve remission with single-agent chemotherapy. Etoposide-based multi-drug regimens form the core...
9.
Elias K, Braga A, Horowitz N, Berkowitz R
Hematol Oncol Clin North Am
. 2024 Sep;
38(6):xiii-xv.
PMID: 39306547
No abstract available.
10.
Elias K, Berkowitz R, Horowitz N
Hematol Oncol Clin North Am
. 2024 Sep;
38(6):1287-1295.
PMID: 39244451
Gestational trophoblastic neoplasia (GTN) is primarily treated with chemotherapy, but surgery plays a key role at different steps in disease management, including initial diagnosis, primary therapy, and salvage options. Initial...